Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer
Clinical trial NCT04008511 · UNKNOWN
Trial details
- NCT number
- NCT04008511
- Sponsor
- China Medical University, China
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2023-03-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.